Howard M. Gebel

9.8k total citations
171 papers, 6.1k citations indexed

About

Howard M. Gebel is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Howard M. Gebel has authored 171 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Transplantation, 65 papers in Immunology and 61 papers in Surgery. Recurrent topics in Howard M. Gebel's work include Renal Transplantation Outcomes and Treatments (80 papers), Transplantation: Methods and Outcomes (35 papers) and Organ Transplantation Techniques and Outcomes (29 papers). Howard M. Gebel is often cited by papers focused on Renal Transplantation Outcomes and Treatments (80 papers), Transplantation: Methods and Outcomes (35 papers) and Organ Transplantation Techniques and Outcomes (29 papers). Howard M. Gebel collaborates with scholars based in United States, Canada and United Kingdom. Howard M. Gebel's co-authors include Robert A. Bray, W. Paul Dmowski, Peter Nickerson, Donald P. Braun, Nasir Rana, Anat R. Tambur, Richard G. Lynch, Carlos Rotman, Anita S. Chong and Robert V. House and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Howard M. Gebel

164 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard M. Gebel United States 46 3.1k 2.3k 2.2k 810 690 171 6.1k
Jean‐Luc Taupin France 37 1.5k 0.5× 1.1k 0.5× 2.3k 1.0× 227 0.3× 890 1.3× 167 4.6k
René J. Duquesnoy United States 55 3.9k 1.2× 3.6k 1.6× 3.0k 1.3× 18 0.0× 644 0.9× 236 8.3k
Helmut Hopfer Switzerland 33 1.1k 0.3× 751 0.3× 714 0.3× 27 0.0× 1.2k 1.8× 94 5.0k
Alberto Sánchez‐Fueyo United Kingdom 42 1.9k 0.6× 2.1k 0.9× 3.0k 1.3× 29 0.0× 856 1.2× 118 6.4k
Vincent Audard France 35 747 0.2× 937 0.4× 447 0.2× 36 0.0× 906 1.3× 182 4.8k
Behdad Afzali United Kingdom 33 446 0.1× 424 0.2× 2.4k 1.1× 25 0.0× 663 1.0× 85 4.2k
Jacques Dantal France 39 2.6k 0.8× 1.8k 0.8× 774 0.3× 14 0.0× 623 0.9× 147 5.8k
Zoltán Lászik United States 27 363 0.1× 493 0.2× 1.0k 0.5× 21 0.0× 998 1.4× 87 3.9k
X. Long Zheng United States 43 194 0.1× 380 0.2× 3.8k 1.7× 51 0.1× 678 1.0× 181 5.9k
FR Appelbaum United States 63 628 0.2× 776 0.3× 3.4k 1.5× 222 0.3× 1.4k 2.0× 189 12.4k

Countries citing papers authored by Howard M. Gebel

Since Specialization
Citations

This map shows the geographic impact of Howard M. Gebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard M. Gebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard M. Gebel more than expected).

Fields of papers citing papers by Howard M. Gebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard M. Gebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard M. Gebel. The network helps show where Howard M. Gebel may publish in the future.

Co-authorship network of co-authors of Howard M. Gebel

This figure shows the co-authorship network connecting the top 25 collaborators of Howard M. Gebel. A scholar is included among the top collaborators of Howard M. Gebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard M. Gebel. Howard M. Gebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Anna B., et al.. (2024). Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups. Human Immunology. 85(6). 111115–111115.
2.
O’Leary, Jacqueline G., Alton B. Farris, Howard M. Gebel, et al.. (2023). Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSA. Transplantation Direct. 9(8). e1500–e1500. 1 indexed citations
3.
Lefaucheur, Carmen, Kévin Louis, Anna B. Morris, et al.. (2023). Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. American Journal of Transplantation. 23(1). 115–132. 38 indexed citations
4.
Gragert, Loren, Matthew Kadatz, Darren Stewart, et al.. (2022). ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation. American Journal of Transplantation. 22(12). 3093–3100. 9 indexed citations
5.
Bray, Robert A., Deepali Kumar, Remi Shih, et al.. (2020). Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins. Transplantation. 105(1). 79–89. 30 indexed citations
6.
Tambur, Anat R., Patricia Campbell, Anita S. Chong, et al.. (2020). Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. American Journal of Transplantation. 20(10). 2652–2668. 80 indexed citations
7.
Parsons, Ronald F., Harold C. Sullivan, F. Eun‐Hyung Lee, et al.. (2019). The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients. American Journal of Transplantation. 20(2). 573–581. 21 indexed citations
8.
Greenshields, Anna L., Robert A. Bray, Howard M. Gebel, & Robert Liwski. (2017). P023 Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the labscreen single antigen bead (SAB) assay. Human Immunology. 78. 70–70. 1 indexed citations
9.
Liwski, Robert & Howard M. Gebel. (2017). Of Cells and Microparticles. Transplantation. 102(1S). S1–S6. 23 indexed citations
10.
Morris, Alanna A., Robert T. Cole, Emir Veledar, et al.. (2013). Influence of Race/Ethnic Differences in Pre-Transplantation Panel Reactive Antibody on Outcomes in Heart Transplant Recipients. Journal of the American College of Cardiology. 62(24). 2308–2315. 47 indexed citations
11.
Reed, Elaine F., P. Nagesh Rao, Zuo‐Feng Zhang, et al.. (2013). Comprehensive Assessment and Standardization of Solid Phase Multiplex-Bead Arrays for the Detection of Antibodies to HLA. American Journal of Transplantation. 13(7). 1859–1870. 173 indexed citations
12.
Bradley, J. Andrew, William M. Baldwin, Adam W. Bingaman, et al.. (2011). Antibody-Mediated Rejection—An Ounce of Prevention Is Worth a Pound of Cure. American Journal of Transplantation. 11(6). 1131–1139. 20 indexed citations
13.
Saw, C., Robert A. Bray, & Howard M. Gebel. (2008). Cytotoxicity and antibody binding by flow cytometry: A single assay to simultaneously assess two parameters. Cytometry Part B Clinical Cytometry. 74B(5). 287–294. 17 indexed citations
14.
Bray, Robert A., et al.. (2004). Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Human Immunology. 65(3). 240–244. 41 indexed citations
15.
Pressly, Thomas A., Howard M. Gebel, Edgar L. Milford, et al.. (2002). Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Rheumatology International. 22(2). 71–76. 9 indexed citations
16.
Chong, Anita S., Alison Finnegan, Howard M. Gebel, et al.. (1993). LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENT. Transplantation. 55(6). 1361–1366. 73 indexed citations
17.
Braun, Donald P., Howard M. Gebel, Carlos Rotman, Nasir Rana, & W. Paul Dmowski. (1992). The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertility and Sterility. 57(6). 1203–1210. 68 indexed citations
18.
Coon, John S., et al.. (1991). Multidrug resistance activity in human lymphocytes. Human Immunology. 32(2). 134–140. 89 indexed citations
19.
Karr, Robert W., Carol C. Kannapell, Judy Stein, et al.. (1982). Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.. The Journal of Experimental Medicine. 156(2). 652–657. 24 indexed citations
20.
Gebel, Howard M., R G Hoover, & Richard G. Lynch. (1979). Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.. PubMed. 123(3). 1110–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Luc Taupin Breakdown of academic impact, for papers by René J. Duquesnoy Breakdown of academic impact, for papers by Helmut Hopfer Breakdown of academic impact, for papers by Alberto Sánchez‐Fueyo Breakdown of academic impact, for papers by Vincent Audard Breakdown of academic impact, for papers by Behdad Afzali Breakdown of academic impact, for papers by Jacques Dantal Breakdown of academic impact, for papers by Zoltán Lászik Breakdown of academic impact, for papers by X. Long Zheng Breakdown of academic impact, for papers by FR Appelbaum
Rankless by CCL
2026